Trial Identifier: | D5160C00006 |
Sponsor: | AstraZeneca |
NCTID:: | NCT02143466 |
Start Date: | August 2014 |
Primary Completion Date: | March 2020 |
Study Completion Date: | December 2023 |
Condition: | Lung Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
CA, AB | Calgary, AB, CA, T2N 4N2 |
CA, AB | Edmonton, AB, CA, T6G 1Z2 |
JP | Chuo-ku, JP, 104-0045 |
JP | Habikino-shi, JP, 583-8588 |
JP | Hirakata-shi, JP, 573-1191 |
JP | Kashiwa, JP, 227-8577 |
JP | Nagoya-shi, JP, 464-8681 |
JP | Nagoya-shi, JP, 460-0001 |
KR | Cheongju-si, KR, 28644 |
KR | Goyang-si, KR, 10408 |
KR | Seongnam-si, KR, 13620 |
KR | Seoul, KR, 05505 |
KR | Seoul, KR, 03722 |
KR | Seoul, KR, 6351 |
PL | Gdańsk, PL, 80-214 |
PL | Kraków, PL, 31-202 |
PL | Olsztyn, PL, 10-357 |
PL | Poznań, PL, 60-569 |
PL | Warszawa, PL, 02-781 |
RU | Chelyabinsk, RU, 454087 |
RU | Krasnoyarsk, RU, 660133 |
RU | Moscow, RU, 115478 |
RU | Omsk, RU, 644013 |
RU | Saint Petersburg, RU, 197342 |
RU | Saint Petersburg, RU, 195271 |
RU | Saint-Petersburg, RU, 197758 |
RU | St. Petersburg, RU, 197022 |
RU | St. Petersburg, RU, 197758 |
RU | St. Petersburg, RU, 197002 |
TW | Kaohsiung, TW, 82445 |
TW | Kaohsiung City, TW, 83301 |
TW | Tainan, TW, 704 |
TW | Taipei, TW, 112 |
TW | Taipei, TW, 235 |
TW | Taipei, TW, 10002 |
UA | Kyiv, UA, 03022 |
UA | Vinnytsia, UA, 21029 |
US, GA | Atlanta, GA, US, 30329 |
US, MA | Boston, MA, US, 02215 |
US, MA | Boston, MA, US, 02114 |
US, NY | New York, NY, US, 10065 |
US, PA | Philadelphia, PA, US, 19111 |
US, TN | Nashville, TN, US, 37232 |